June 24, 2026 · Form 4 insider transaction
Krasney Karen sold 400 shares of Capricor Therapeutics, Inc. at $30.00 per share, a transaction worth $12.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.